DeFi Technologies Refiles 2023 Annual Financial Statements
September 06, 2024 18:00 ET
|
DeFi Technologies Inc.
TORONTO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (Cboe CA: DEFI) (GR: R9B) (OTC: DEFTF), a financial technology company that pioneers the...
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders
September 06, 2024 17:30 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, Sept. 06, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...
NurExone Demonstrates Extended Therapeutic Window of ExoPTEN Post Spinal-Cord Injury in Preclinical Study
September 06, 2024 16:03 ET
|
NurExone Biologic Inc
NurExone demonstrates a longer timeframe of ExoPTEN treatment can be effectively administered post Spinal-Cord Injury
PTX Metals Inc. Announces Effective Date of Share Consolidation
September 06, 2024 08:00 ET
|
PTX Metals Inc.
TORONTO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- PTX Metals Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PF) (“PTX Metals” or the “Company”) announces that it will consolidate its common shares (the...
Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
September 06, 2024 07:55 ET
|
Clearmind Medicine Inc.
Pioneering Therapeutic Approach Aims to Enhance Safety and Efficacyin Mental Health and Addiction Treatments Vancouver, Canada, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:...
Starke Cresemba® (Isavuconazol)-Verkäufe in Europa lösen USD 25 Mio. Umsatzmeilensteinzahlung an Basilea aus
September 06, 2024 01:15 ET
|
Basilea Pharmaceutica AG, Allschwil
Ad hoc-Mitteilung gemäss Art. 53 KR Allschwil, 6. September 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel,...
Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 25 million sales milestone payment to Basilea
September 06, 2024 01:15 ET
|
Basilea Pharmaceutica AG, Allschwil
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, September 6, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to...
Bedford Metals Provides Corporate Update on Uranium Exploration Progress
September 06, 2024 01:00 ET
|
Bedford Metals Corp.
Bedford Metals provides corporate update about their uranium exploration efforts in the Athabasca Basin.
Alaska Energy Metals Closes $5 Million Special Warrant and Unit Offering; Nikolai Nickel Project Exploration Well Underway With More Than $8.68 Million Recently Raised
September 05, 2024 21:11 ET
|
Alaska Energy Metals Corporation
Highlights: An additional $5,000,000 has been raised in a second round of Special Warrant and Unit offerings, following on from first round offerings totaling $3,679,564 closed in July.More than...
Traction Uranium Announces Proposed Share Consolidation
September 05, 2024 17:35 ET
|
Traction Uranium Corp.
CALGARY, Alberta, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Traction Uranium Corp. (CSE: TRAC) (OTC: TRCTF) (FRA: Z1K) (the “Company” or “Traction”) is pleased to announce that its board of directors has...